Seegene participated in the world-renown diagnostics expo MedLab 2017, which was held in Dubai, UAE from February 6-9, 2017.

Until 2016, MedLab was held in conjunction with Arab Health, the largest medical device trade show in the Middle East. Fueled by the sharp annual increase in the event’s scale, it was featured this year as an independent diagnostics expo for the first time.

At this year’s expo, Seegene Middle East featured the All-in-One Platform, an integrated test platform that can conduct a wide range of molecular diagnostic tests in areas including infectious disease and women’s health. Currently, broad diagnostic products of Seegene can be applied to this consolidated platform including tests for respiratory and gastrointestinal infectious disease, sexually-transmitted diseases, HPV and TB and they are planning to accelerate the increase of applicable test areas.

Seegene Middle East is picking up steam for the company’s entry into the Middle Eastern medical market through local branch offices in countries in the Middle East, including Saudi Arabia, Egypt and Iran. Especially, with diagnostic products for various respiratory diseases (including MERS) approved for supply as the primary screening product at major national hospitals and screening centers, sales growth is expected to continue.

Seegene Middle East President James Jeehoon Park said, “Through this year’s expo, we gain the opportunity to forge new markets in North Africa and areas of the Middle East like Lebanon, Oman and Kuwait in which we have had difficulty gaining a foothold. Because MedLab serves as a barometer of the local medical market, we will continue to participate every year as a key means of improving brand image and market expansion.”